Somatostatin D Cells, also known as delta cells, are a type of endocrine cell found in the pancreatic islets (Islets of Langerhans). These cells play a crucial role in regulating the endocrine function of the pancreas by producing the hormone somatostatin. Somatostatin acts as an inhibitory hormone, regulating the release of various hormones such as insulin and glucagon from neighboring alpha and beta cells in the islets. It exerts its effects by suppressing the secretion of these hormones, thus playing a key role in glucose homeostasis and overall metabolic regulation. The somatostatin D cells are characterized by their distinctive delta-cell morphology and are interspersed among the alpha and beta cells in the pancreatic islets. Delta cells are responsive to changes in blood glucose levels, amino acids, and other factors that influence hormone secretion. The inhibitory actions of somatostatin extend beyond the pancreas, affecting other organs such as the gastrointestinal tract, where it regulates the secretion of various digestive enzymes and inhibits gastric acid release. Somatostatin D cells contribute to the maintenance of physiological balance and prevent excessive hormonal fluctuations, helping to ensure stability in metabolic processes. Dysregulation of somatostatin secretion may be associated with disorders like diabetes mellitus. Research on somatostatin D cells provides insights into their role in endocrine regulation and potential therapeutic applications. Somatostatin analogs are used in clinical settings to treat conditions like acromegaly and neuroendocrine tumors, highlighting the clinical significance of understanding delta cell function and somatostatin biology.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States